Search research articles
Contact Us
Filters
Showing results (601-610 of 625) with videos related to
Page
of 63
Sort By:
Nature Communications
|
March 3, 2023
Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans
Kodihalli C Ravindra, Vishal S Vaidya, Zhenyu Wang, et al.
Journal of Gastroenterology
|
April 15, 2024
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
Diagnostic and Prognostic Research
|
September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control study
Jane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Journal of Proteome Research
|
February 28, 2012
Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression
J Barr, J Caballería, I Martínez-Arranz, et al.
Alimentary Pharmacology & Therapeutics
|
May 2, 2024
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Juan Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, et al.
Journal of Hepatology
|
May 18, 2016
Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury
Inmaculada Medina-Caliz, Mercedes Robles-Diaz, Beatriz Garcia-Muñoz, et al.
The American Journal of Gastroenterology
|
June 23, 2021
Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study
Anna Reig, Carmen Álvarez-Navascués, Mercedes Vergara, et al.
United European Gastroenterology Journal
|
June 19, 2024
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression
Rocío Gallego-Durán, Javier Ampuero, Douglas Maya-Miles, et al.
Gastroenterology
|
May 17, 2011
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles
M Isabel Lucena, Mariam Molokhia, Yufeng Shen, et al.
Ebiomedicine
|
March 25, 2026
Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injury
Maria J Monte, Thi Dong-Binh Tran, Jane I Grove, et al.
Page
of 63
Search research articles
Search
Showing results (601-610 of 625) with videos related to
Sort By:
Page
of 63
Nature Communications
|
March 3, 2023
Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans
Kodihalli C Ravindra, Vishal S Vaidya, Zhenyu Wang, et al.
Journal of Gastroenterology
|
April 15, 2024
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
Diagnostic and Prognostic Research
|
September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control study
Jane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Journal of Proteome Research
|
February 28, 2012
Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression
J Barr, J Caballería, I Martínez-Arranz, et al.
Alimentary Pharmacology & Therapeutics
|
May 2, 2024
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Juan Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, et al.
Journal of Hepatology
|
May 18, 2016
Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury
Inmaculada Medina-Caliz, Mercedes Robles-Diaz, Beatriz Garcia-Muñoz, et al.
The American Journal of Gastroenterology
|
June 23, 2021
Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study
Anna Reig, Carmen Álvarez-Navascués, Mercedes Vergara, et al.
United European Gastroenterology Journal
|
June 19, 2024
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression
Rocío Gallego-Durán, Javier Ampuero, Douglas Maya-Miles, et al.
Gastroenterology
|
May 17, 2011
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles
M Isabel Lucena, Mariam Molokhia, Yufeng Shen, et al.
Ebiomedicine
|
March 25, 2026
Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injury
Maria J Monte, Thi Dong-Binh Tran, Jane I Grove, et al.
Page
of 63